Cargando…
EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia in Greece
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747382/ http://dx.doi.org/10.1016/j.jval.2022.09.634 |
| _version_ | 1784849584094183424 |
|---|---|
| author | Yfantopoulos, N Bafaloukos, I Yang, J Mintzia, E Ntontsi, P Skroumpelos, A Karokis, A |
| author_facet | Yfantopoulos, N Bafaloukos, I Yang, J Mintzia, E Ntontsi, P Skroumpelos, A Karokis, A |
| author_sort | Yfantopoulos, N |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9747382 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97473822022-12-14 EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia in Greece Yfantopoulos, N Bafaloukos, I Yang, J Mintzia, E Ntontsi, P Skroumpelos, A Karokis, A Value Health Article Published by Elsevier Inc. 2022-12 2022-12-14 /pmc/articles/PMC9747382/ http://dx.doi.org/10.1016/j.jval.2022.09.634 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Yfantopoulos, N Bafaloukos, I Yang, J Mintzia, E Ntontsi, P Skroumpelos, A Karokis, A EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia in Greece |
| title | EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia in Greece |
| title_full | EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia in Greece |
| title_fullStr | EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia in Greece |
| title_full_unstemmed | EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia in Greece |
| title_short | EE388 Cost Effectiveness of Novel Antibiotic Ceftolozane/Tazobactam in Patients With Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia in Greece |
| title_sort | ee388 cost effectiveness of novel antibiotic ceftolozane/tazobactam in patients with hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia in greece |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747382/ http://dx.doi.org/10.1016/j.jval.2022.09.634 |
| work_keys_str_mv | AT yfantopoulosn ee388costeffectivenessofnovelantibioticceftolozanetazobactaminpatientswithhospitalacquiredbacterialpneumoniaorventilatorassociatedbacterialpneumoniaingreece AT bafaloukosi ee388costeffectivenessofnovelantibioticceftolozanetazobactaminpatientswithhospitalacquiredbacterialpneumoniaorventilatorassociatedbacterialpneumoniaingreece AT yangj ee388costeffectivenessofnovelantibioticceftolozanetazobactaminpatientswithhospitalacquiredbacterialpneumoniaorventilatorassociatedbacterialpneumoniaingreece AT mintziae ee388costeffectivenessofnovelantibioticceftolozanetazobactaminpatientswithhospitalacquiredbacterialpneumoniaorventilatorassociatedbacterialpneumoniaingreece AT ntontsip ee388costeffectivenessofnovelantibioticceftolozanetazobactaminpatientswithhospitalacquiredbacterialpneumoniaorventilatorassociatedbacterialpneumoniaingreece AT skroumpelosa ee388costeffectivenessofnovelantibioticceftolozanetazobactaminpatientswithhospitalacquiredbacterialpneumoniaorventilatorassociatedbacterialpneumoniaingreece AT karokisa ee388costeffectivenessofnovelantibioticceftolozanetazobactaminpatientswithhospitalacquiredbacterialpneumoniaorventilatorassociatedbacterialpneumoniaingreece |